Zurich Cantonal Bank
SRNE

Zurich Cantonal Bank’s Sorrento Therapeutics, Inc. SRNE Stock Holding History

Zurich Cantonal Bank’s Portfolio SRNE Stock Details SRNE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-48,865
Closed -$43.3K – 2901
2022
Q4 		$43.3K Sell
48,865
-63
-0.1% -$84 ﹤0.01% 2639
2022
Q3 		$77K Sell
48,928
-154
-0.3% -$349 ﹤0.01% 2405
2022
Q2 		$99K Sell
49,082
-1,492
-3% -$2.58K ﹤0.01% 2259
2022
Q1 		$118K Sell
50,574
-150
-0.3% -$468 ﹤0.01% 2211
2021
Q4 		$236K Buy
50,724
+8,656
+21% +$53.7K ﹤0.01% 1958
2021
Q3 		$321K Hold
42,068
– – ﹤0.01% 1589
2021
Q2 		$408K Buy
42,068
+817
+2% +$6.51K ﹤0.01% 1353
2021
Q1 		$341K Buy
41,251
+12,138
+42% +$128K ﹤0.01% 1465
2020
Q4 		$199K Buy
29,113
+11,313
+64% +$90.9K ﹤0.01% 1847
2020
Q3 		$198K Hold
17,800
– – ﹤0.01% 1597
2020
Q2 		$112K Buy
+17,800
New +$68.1K ﹤0.01% 1887
2019
Q4 		– Sell
-8,966
Closed -$19K – 2642
2019
Q3 		$19K Hold
8,966
– – ﹤0.01% 2468
2019
Q2 		$24K Buy
8,966
+3,731
+71% +$13.4K ﹤0.01% 2423
2019
Q1 		$25K Hold
5,235
– – ﹤0.01% 2358
2018
Q4 		$13K Buy
+5,235
New +$17.1K ﹤0.01% 2529

Other funds holding SRNE

PP
Paloma Partners Greenwich, Connecticut $1.36B AUM 249.29% 1-Year Est. Return
OCM
Oaktree Capital Management Los Angeles, California $7.21B AUM 45.97% 1-Year Est. Return
OFA
Oaktree Fund Advisors Los Angles, California $57.8M AUM 67.22% 1-Year Est. Return
CGA
Crescent Grove Advisors Lake Forest, Illinois $1.2B AUM 23.08% 1-Year Est. Return
LCM
Lattice Capital Management Kirkland, Washington $49.5M AUM 28.58% 1-Year Est. Return
STB
S&T Bank Indiana, Pennsylvania $333M AUM 106.39% 1-Year Est. Return
GA
GoalVest Advisory New York $539M AUM 27.49% 1-Year Est. Return
HFRG
Houlihan Financial Resource Group Ashburn, Virginia $281M AUM 17.68% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
GBWM
Granite Bay Wealth Management Portsmouth, New Hampshire $1.09B AUM 22.93% 1-Year Est. Return

Zurich Cantonal Bank's SRNE Position: Q1 2023 in Review

Zurich Cantonal Bank sold out of Sorrento Therapeutics, Inc. (SRNE) in Q1 2023, closing a stake of 48,865 shares — an estimated $43.3K sold.

Zurich Cantonal Bank first reported a position in SRNE in Q4 2018 and held it in 15 quarters. The position peaked at $408K in Q2 2021. 34 funds tracked by Wall St. Rank hold SRNE as of Q1 2023.

  • Zurich Cantonal Bank reported no remaining Sorrento Therapeutics, Inc. position as of Q1 2023 after selling out during the quarter.
  • Zurich Cantonal Bank sold 48,865 Sorrento Therapeutics, Inc. shares in Q1 2023, an estimated $43.3K.
  • Zurich Cantonal Bank first reported a position in Sorrento Therapeutics, Inc. in Q4 2018 and held it in 15 quarters.
  • Zurich Cantonal Bank's Sorrento Therapeutics, Inc. position peaked at $408K in Q2 2021.
  • 34 funds tracked by Wall St. Rank held Sorrento Therapeutics, Inc. as of Q1 2023.

Based on Zurich Cantonal Bank's 13F filing for Q1 2023, filed 8 May 2023.